Amgen to acquire DeCODE for $415 million

Genome-based drug discovery received a lift on Monday with the announcement that Amgen Inc has agreed to pay $415 million in cash for DeCODE Genetics of Iceland, long considered to be a leader in population-based studies of human disease.